Management of Oropharynx Cancer and Associated Toxicities is organized by American Society for Radiation Oncology (ASTRO) and will be held from Feb 08, 2017 - Feb 07, 2020.
The target audience for this medical event is radiation oncologists, medical oncologists, surgeons and residents in training. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credits.
This course will describe the presentation, evaluation, and management of patients with oropharyngeal cancers, especially with regard to the importance of multidisciplinary management of patients with HPV-related cancers. The optimal evaluation of a patient at diagnosis and the importance of HPV-status in counseling will be reviewed; the role of radiation, chemotherapy, and surgery will also be discussed. Radiation techniques, such as IMRT, IGRT, and proton therapy, will be reviewed comprehensively, including details of contouring and integrating chemotherapy and surgery. The last portion of the course will discuss details of managing the need for target delineation and normal tissue protection, with review of the organs at risk and data on optimal normal tissue.
• Explain the issues related to HPV-related oropharyngeal cancer and provide appropriate patient evaluation and counseling.
• Explain the issues and details involved in appropriate radiation-based treatment, including the use of IMRT, IGRT, and proton therapy.
• Implement normal structure dose constraints and counsel patients regarding side effects and possible complications of radiation-based therapy of oropharynx cancer.
Additional details will be posted as soon as they are available.